CARE Ratings Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals

Technical Trend Overview and Price Movement

CARE Ratings Ltd, currently priced at ₹1,600.00, closed lower than its previous close of ₹1,614.60, marking a day change of -0.90%. The stock’s intraday range spanned from ₹1,600.00 to ₹1,629.85, indicating some volatility but an inability to sustain gains above the previous close. The 52-week high stands at ₹1,964.80, while the 52-week low is ₹1,057.65, placing the current price closer to the upper half of its annual range.

The technical trend has shifted from mildly bullish to mildly bearish, signalling a cautious stance among traders and investors. This shift is corroborated by the daily moving averages, which currently indicate a bearish trend, suggesting that short-term momentum is weakening. The moving averages’ bearish signal often reflects selling pressure or a potential correction phase following prior gains.

MACD and RSI Signals

The Moving Average Convergence Divergence (MACD) indicator presents a mildly bearish signal on both weekly and monthly charts. This suggests that the momentum behind the stock’s price movement is losing strength, with the MACD line likely crossing below the signal line or remaining below it, a classic bearish indicator. The MACD’s mildly bearish stance aligns with the recent price decline and the bearish moving averages.

Conversely, the Relative Strength Index (RSI) on both weekly and monthly timeframes shows no definitive signal, hovering in a neutral zone. This lack of a clear RSI signal implies that the stock is neither overbought nor oversold, indicating a balanced momentum without extreme price pressures. The neutral RSI suggests that while the stock is experiencing some selling pressure, it has not yet reached a level that would typically trigger a reversal or strong buying interest.

Bollinger Bands and KST Indicator Insights

Bollinger Bands provide a slightly more optimistic view. On the weekly chart, the bands are mildly bullish, while the monthly chart shows a bullish signal. This indicates that despite short-term weakness, the stock price is maintaining a position near the upper band on a longer-term basis, suggesting underlying strength and potential for upward movement if volatility contracts favourably.

The Know Sure Thing (KST) indicator adds further complexity. It is bullish on the weekly timeframe but mildly bearish on the monthly chart. This divergence highlights a short-term positive momentum that is not yet confirmed on a longer-term basis, signalling that traders should exercise caution and monitor for confirmation of trend direction.

Volume and Dow Theory Analysis

On-Balance Volume (OBV) presents a mixed picture with a mildly bearish weekly signal but a bullish monthly signal. This suggests that while recent trading volumes may have been skewed towards selling, the longer-term volume trend supports accumulation, which could underpin future price support.

Dow Theory assessments also reflect this duality. The weekly chart is mildly bullish, indicating short-term positive price action, whereas the monthly chart shows no clear trend. This lack of a monthly trend confirmation advises prudence, as the stock may be in a consolidation phase or awaiting a catalyst to define its longer-term direction.

Comparative Returns and Market Context

CARE Ratings Ltd’s price momentum must be viewed in the context of its returns relative to the broader market. Over the past week, the stock declined by 0.57%, outperforming the Sensex’s sharper fall of 1.84%. Over one month, CARE Ratings gained 1.18%, contrasting with the Sensex’s 0.70% decline, signalling relative strength in the short term.

Year-to-date, the stock is essentially flat with a -0.05% return, outperforming the Sensex’s -4.62%. Over longer horizons, CARE Ratings has delivered robust returns: 38.43% over one year, 153.81% over three years, and an impressive 243.75% over five years, significantly outpacing the Sensex’s respective returns of 8.95%, 37.10%, and 65.55%. However, over ten years, the Sensex’s 251.07% return surpasses CARE Ratings’ 79.83%, reflecting broader market cycles and sectoral shifts.

Mojo Score and Analyst Ratings

The company’s current Mojo Score stands at 48.0, with a Mojo Grade downgraded from Hold to Sell as of 23 February 2026. This downgrade reflects the recent technical deterioration and cautious outlook from MarketsMOJO’s analytical framework. The Market Cap Grade is 3, indicating a mid-tier capitalisation within the capital markets sector. The downgrade signals that investors should be wary of near-term downside risks despite the company’s strong historical performance.

Investor Takeaway and Outlook

CARE Ratings Ltd’s technical indicators present a nuanced picture. The shift to a mildly bearish trend on key momentum indicators such as MACD and moving averages suggests caution in the near term. However, the bullish signals from Bollinger Bands and KST on shorter timeframes, combined with strong long-term returns, indicate that the stock retains underlying strength.

Investors should closely monitor the stock’s ability to hold above key support levels near ₹1,600 and watch for confirmation from volume trends and monthly indicators. The neutral RSI and mixed Dow Theory signals imply that the stock could consolidate before making a decisive move. Given the recent downgrade to a Sell grade, a conservative approach is advisable, especially for short-term traders.

Long-term investors may find value in CARE Ratings’ historical outperformance relative to the Sensex, but should remain vigilant for signs of trend reversal or sustained weakness. The stock’s position within the capital markets sector and its mid-tier market capitalisation further underscore the importance of sectoral and macroeconomic factors in shaping its trajectory.

Summary

In summary, CARE Ratings Ltd is navigating a technical transition marked by mixed signals. While short-term momentum indicators have weakened, longer-term trends and volume patterns suggest potential resilience. The downgrade in Mojo Grade to Sell reflects this cautious stance, urging investors to weigh risks carefully against the company’s strong historical performance and sector dynamics.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →